Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Latest News

UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC

globenewswire.com
URGN

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

globenewswire.com
INMB

CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients

globenewswire.com
CGON

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

globenewswire.com
ATYR

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results

globenewswire.com
COCP

MANTECH Names Sarah Carter as Chief Growth Officer

globenewswire.com
MNTK

Perma-Fix Announces Pricing of $20.0 Million Public Offering of Common Stock

globenewswire.com
PESI

H World Group Reports Q1 Results, Highlighting Asset-light Growth and Expanding APAC Footprint

prnewswire.com
HTHT

Sharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury Execution

prnewswire.com
STSS

U.S. Gold Corp. to Attend Several Investor Conferences in May and June 2026 English

prnewswire.com
USAU